Search research articles
Contact Us
Filters
Showing results (231-240 of 239) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 239 results.
Circulation
|
June 29, 1999
Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A
G Bilder, T Wentz, R Leadley, et al.
The European Respiratory Journal
|
August 6, 2016
Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre
Ganesh Raghu, Ellen Morrow, Bridget F Collins, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 29, 2011
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency
E Ferrante, A E Malavazos, C Giavoli, et al.
European Journal of Endocrinology
|
November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients
M Filopanti, A M Barbieri, G Mantovani, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 1999
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA
Y M Choi-Sledeski, M R Becker, D M Green, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study
M Filopanti, L Olgiati, G Mantovani, et al.
International Journal of Cancer
|
January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
E Peverelli, E Giardino, D Treppiedi, et al.
The Pharmacogenomics Journal
|
March 12, 2008
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
M Filopanti, A M Barbieri, A R Angioni, et al.
Journal of Endocrinological Investigation
|
April 23, 2022
Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment
G Marcucci, G Beccuti, G Carosi, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 239) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 239 results.
Circulation
|
June 29, 1999
Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A
G Bilder, T Wentz, R Leadley, et al.
The European Respiratory Journal
|
August 6, 2016
Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre
Ganesh Raghu, Ellen Morrow, Bridget F Collins, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 29, 2011
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency
E Ferrante, A E Malavazos, C Giavoli, et al.
European Journal of Endocrinology
|
November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients
M Filopanti, A M Barbieri, G Mantovani, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 1999
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA
Y M Choi-Sledeski, M R Becker, D M Green, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study
M Filopanti, L Olgiati, G Mantovani, et al.
International Journal of Cancer
|
January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
E Peverelli, E Giardino, D Treppiedi, et al.
The Pharmacogenomics Journal
|
March 12, 2008
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
M Filopanti, A M Barbieri, A R Angioni, et al.
Journal of Endocrinological Investigation
|
April 23, 2022
Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment
G Marcucci, G Beccuti, G Carosi, et al.
Page
of 24